| Document Date: 2015-04-22 23:39:46
Open Document File Size: 150,11 KBShare Result on Facebook
City Barcelona / / Company Lundbeck Australia Pty Ltd. / AEs / / Country United States / Spain / / Currency USD / EUR / / Event FDA Phase / / Facility Consumer Comments facility / European College of Neuropsychopharmacology / / MedicalCondition aripiprazole Psychotic disorders / schizophrenia / disease / psychiatric illness / ASPIRE US akathisia / pain / Psychotic disorders / S328 schizophrenia / acutely exacerbated schizophrenia / illness / acutely symptomatic schizophrenia / Akathisia / / Organization European College of Neuropsychopharmacology / International Congress / European Union / Medicare Australia PBS / / Person ARI LAI PBO PP LAI / Kane Long-acting / Arch Psychiatry / Gopal Efficacy / ARI LAI ARI LAI PBO / Kane Aripiprazole / / / Position TGA Clinical Evaluator / Trial ID/ First Author / / Product Event rate/100 patients* Aripiprazole Aripiprazole LAI tablets / olanzapine / Harms Injection / haloperidol / ARI tablets / Aripiprazole LAI Aripiprazole tablets / risperidone / Abilify / Aripiprazole tablets / Aripiprazole / / PublishedMedium Commentary / the American Journal / /
SocialTag |
Microsoft Word - Lundbeck- 5-2 aripiprazolePSD final.docx